排序方式: 共有96条查询结果,搜索用时 15 毫秒
1.
目的 研究超声引导下股神经阻滞和坐骨神经阻滞在急诊膝关节以下手术中的应用价值.方法 40例小腿、足部或膝关节外伤,拟行清创缝合手术的患者,随机分成两组:超声组和对照组,每组20例.行患侧股神经和腘窝坐骨神经阻滞,对照组采用传统的方法定位穿刺,超声组采用超声引导下定位.在穿刺点注入1.5%利多卡因.在30 min内每5 min观察1次感觉阻滞的效果.记录局麻药起效时间、感觉阻滞效果,镇痛维持时间、并发症.用t检验和χ2检验比较两组间的差异.结果 超声组的患者局部麻醉药的起效时间比对照组短,超声组镇痛效果优于对照组.结论 超声引导下股神经阻滞和坐骨神经阻滞比传统阻滞方法效果好. 相似文献
2.
目的:对比3D和2D腹腔镜治疗直肠癌的临床近期效果。方法:回顾性分析经腹腔镜行Miles及Dixon术根治性切除直肠癌患者35例临床资料。根据所用腹腔镜类型分为3D腹腔镜组(18例)和2D腹腔镜组(17例),比较两组近期疗效。结果:3D和2D腹腔镜组在年龄、性别、肿瘤分期、术式等方面差异均无统计学意义(P0.05);3D腹腔镜组手术时间较2D腹腔镜组明显缩短(P0.05),两组中转开腹率、术中出血量、排气时间、留置导尿管时间、并发症发生率差异无统计学意义(P0.05);平均随访时间为(13.28±2.15)个月。3D腹腔镜组随访期间复发率和病死率分别为44.44%和16.67%,2D腹腔镜组分别为41.18%和17.65%(P0.05)。结论:3D腹腔镜直肠癌根治术较2D腹腔镜直肠癌根治术缩短了手术时间;近期临床疗效无明显差异。 相似文献
3.
目的探讨防治胃肠道恶性肿瘤合并阻塞性肺疾病(COPD)患者术后并发症的有效方法。方法回顾性分析60例胃肠道恶性肿瘤合并COPD患者的围手术期处理措施及其效果。结果术后11例患者出现并发症(18.3%),其中肺炎5例(8.3%),肺不张1例(1.7%),切口感染2例(3.3%),吻合口漏1例(1.7%),泌尿系感染1例(1.7%),肠梗阻1例(1.7%)。除1例肺炎发展为MODS死亡外,其余经非手术治疗后痊愈。结论围手术期采取综合措施可有效降低胃肠道恶性肿瘤合并COPD患者术后并发症的发生。 相似文献
4.
目的探讨胃肠道恶性肿瘤合并活动性肺结核患者的处理策略。方法回顾性分析9例合并活动性肺结核胃肠道恶性肿瘤患者诊治资料。结果术前给予2周乙氨丁醇、异烟肼、利福平及吡嗪酰胺(EIRP)或异烟肼、利福平及吡嗪酰胺(IRP)强化联合抗结核病治疗后,所有患者均接受根治性肿瘤切除术,术后静脉给予异烟肼或二线抗结核药,患者可以口服时继用术前抗结核强化方案。术后2例并发肺炎,无结核播散恶化或死亡病例。7例术后强化治疗2个月痰菌转阴后改为异烟肼及利福平(IR)巩固治疗。在抗结核治疗巩固期同时行FOLFOX4或CapeOX方案化疗8疗程,无结核恶化病例。结论胃肠道恶性肿瘤合并活动性肺结核术前给予强化抗结核治疗2周后可行手术。术后可静脉给予抗结核药物。患者可以口服后可继用术前抗结核强化治疗。于抗结核巩固期开始肿瘤化疗安全可行。 相似文献
5.
Objective To observe the gene silencing and disruption of WNT pathway mediated by the specific shRNA targeted against β-catenin and its effect on cell proliferation of the human colon cancer cell line Colo205. Methods The shRNA plasmid vectors against β-catenin were constructed and transfected into Colo205 ceils with LipofectamineTM 2000. The expression of β-catenin was detected by RT-PCR and Western blot. Immunofluorescence staining was also performed to detect the β-catenin protein expression in cells. The cell proliferation inhibition was determined by MTT assay and soft agar colony formation assay. Results The shRNA vectors targeted against β-catenin were successfully constructed and efficiently suppressed the expression of β-catenin mRNA and protein (P<0.05). The expression inhibition rates were 47.89% and 45.26% at the mRNA and protein level respectively. Immunofluorescence microscopy also demonstrated the inhibition of β-catenin protein induced by these specific shRNAs. The MTT assay indicated that the specific shRNA resulted in significant inhibition of cell growth on the culture plates in time-dependent manner. At 72 h post-transfection, the cell viability of CAT group was 48.5%, which was significantly different as compared with that of blank control group's 91.3%(P<0.05). In the soft agar, there were 9, 46, 43 cell colonies in the CAT, blank, and negative control groups respectively, which were significantly different (P<0.05). Conclusions The specific shRNAs targeted against β-catenin has a gene silencing effect and blocks the WNT signaling pathway, which can inhibit the growth of Colo205 cells. 相似文献
6.
目的:探讨新型抗精神病药物阿立哌唑治疗急性复发精神分裂症的有效性和安全性。方法:随机入组症状急性恶化或复发的精神分裂症患者30例(脱落1例),纳入分析29例(男15例,女14例),采用阿立哌唑治疗,剂量为(14.4±9.2)mg·d-1,临床观察6周。采用阳性症状与阴性症状量表(PANSS)评定疗效,用不良反应症状量表(TESS)、血生化指标和心电图的改变评价治疗的安全性。结果:①治疗1周后,PANSS阳性、阴性症状分和总分均显著下降(P<0.05);治疗6周后PANSS各分值(阳性症状分为15.5±6.1,阴性症状分为15.1±7.0,总分为60.4±18.1)与基线水平(阳性症状分为26.8±7.1,阴性症状分为22.1±8.4,总分为96.4±21.0)差异显著(P<0.01)。②经6周治疗,基本痊愈6例(20.7%),好转共12例(41.4%),症状无显著变化11例(37.9%),1例患者病情有恶化。③治疗过程中,所有患者TESS总分平均值(2.0±2.3),其中12例患者评分一直为0;主要表现为失眠、静坐不能、食欲减退、便秘、视物模糊。6周的观察中未发现阿立哌唑导致的体重显著增加和心电图的明显改变。结论:阿立哌唑对急性复发的精神分裂症有良好的疗效,而且不良反应较小。 相似文献
7.
目的 了解行为疗法在国内的研究概况及发展趋势。方法 采用文献计量学方法对《CBMdisc》中 1981~ 2 0 0 0年行为疗法文献的动态分布、主题分布进行分析。结果 ①国内行为疗法已进入文献量呈指数增长的学科大发展时期 ;②国内行为疗法以行为纠正、生物反馈及认知疗法应用较多 ,行为纠正和生物反馈已用于临床各科 ,应用最多的为心血管系统及神经内科疾病 ;认知疗法主要用于精神障碍 ;厌恶性疗法主要用于物质戒断 ;系统脱敏用于恐怖症 ;沉思无文献报道 相似文献
8.
文献计量学方法对国内行为疗法发展趋势及研究概况的分析 总被引:4,自引:0,他引:4
目的 了解行为疗法在国内的研究概况及发展趋势。方法 采用文献计量学方法对《CBMdisc》的1981-2000年行为疗法文献的动态分析、主题分布进行分析。结果 ①国内行为疗法已进入文献量呈指数增长的学科大发展时期;②国内行为疗法以行为纠正、生物反馈及认知疗法应用较多,行为纠正和生物反馈已用于临床各科,应用最多的为心血管系统及神经内科疾病;认知疗法主要用于精神障碍;厌恶性疗法主要用于物质戒断;系统脱敏用于恐怖症;沉思无文献报道。 相似文献
9.
Objective To observe the gene silencing and disruption of WNT pathway mediated by the specific shRNA targeted against β-catenin and its effect on cell proliferation of the human colon cancer cell line Colo205. Methods The shRNA plasmid vectors against β-catenin were constructed and transfected into Colo205 ceils with LipofectamineTM 2000. The expression of β-catenin was detected by RT-PCR and Western blot. Immunofluorescence staining was also performed to detect the β-catenin protein expression in cells. The cell proliferation inhibition was determined by MTT assay and soft agar colony formation assay. Results The shRNA vectors targeted against β-catenin were successfully constructed and efficiently suppressed the expression of β-catenin mRNA and protein (P<0.05). The expression inhibition rates were 47.89% and 45.26% at the mRNA and protein level respectively. Immunofluorescence microscopy also demonstrated the inhibition of β-catenin protein induced by these specific shRNAs. The MTT assay indicated that the specific shRNA resulted in significant inhibition of cell growth on the culture plates in time-dependent manner. At 72 h post-transfection, the cell viability of CAT group was 48.5%, which was significantly different as compared with that of blank control group's 91.3%(P<0.05). In the soft agar, there were 9, 46, 43 cell colonies in the CAT, blank, and negative control groups respectively, which were significantly different (P<0.05). Conclusions The specific shRNAs targeted against β-catenin has a gene silencing effect and blocks the WNT signaling pathway, which can inhibit the growth of Colo205 cells. 相似文献
10.
患者 ,男 ,34岁。以咽痛、痰中带血反复发作 1年 ,曾在当地医院诊断为急性化脓性扁桃体炎 ,给予静脉滴注青霉素等药物 ,症状反复。近半个月来咽痛加剧 ,影响进食 ,并有右侧耳痛、耳鸣 ;用力咳嗽时 ,有少许新鲜血从口中流出 ,遂来我院就诊。检查 :右侧扁桃体Ⅲ度肿大 ,表面有褐色伪膜覆盖 ,质脆 ,触之易出血 ,并突向鼻咽部。CT示 :右侧扁桃体肿瘤。于 2 0 0 1年 3月 5日收住院。入院后取活检 ,镜下见 :AntoniA区瘤细胞呈梭形 ,按旋涡状排列 ,AntoniB区瘤细胞呈淋巴样细胞 ,其间有较多小血管穿梭 ,未见神经纤维。病理诊断 :右… 相似文献